J, L., Z, L., D, X., T, Z., A, L., J, H., . . . L, Z. Pretreatment Lipoprotein(a) as a Biomarker for EGFR Mutation and Prognosis in Lung Adenocarcinoma. Dove Medical Press.
Chicago Style (17th ed.) CitationJ, Liu, et al. Pretreatment Lipoprotein(a) as a Biomarker for EGFR Mutation and Prognosis in Lung Adenocarcinoma. Dove Medical Press.
MLA (9th ed.) CitationJ, Liu, et al. Pretreatment Lipoprotein(a) as a Biomarker for EGFR Mutation and Prognosis in Lung Adenocarcinoma. Dove Medical Press.
Warning: These citations may not always be 100% accurate.